06 Mar GenXys has been featured on the 2017 Digital Health Emerging Rocket list
We are delighted to be included in the 2017 selections for the Digital Health Emerging Rockets. This list profiles British Columbia technology companies that will lead market breakthroughs by providing tools and services to facilitate better health.
After a successful 2016, we are looking forward to a fantastic year ahead! Last summer, we published a feasibility study showing that family physicians and pharmacists found our decision support system and genetic test easy to use and implement in their practices, and to be a valuable tool to reduce inappropriate prescribing. Our research also showed that 97% of all the participants in the study had actionable genetic markers for dose changes or contraindication for medications, revealing the importance of implementing genetic testing as a preventive practice in primary care.
In the fall, we were thrilled to announce the launch of our decision support tool and pharmacogenetic test to customers and health care professionals.
We are honored to be recognized by the Ready to Rocket business program! Our smart tools provide safe, effective and personalized prescribing options for patients and health care professionals and will continue enabling personalized care for all.